Hjem › Leverkreft (hepatocellulært karcinom) › Massachusetts
Kliniske studier for Leverkreft (hepatocellulært karcinom) i Massachusetts
19 studier for Leverkreft (hepatocellulært karcinom) søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #7, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05176483National Liver Cancer Screening Trial
- Massachusetts General Hospital, Boston
RekruttererFase 4
Alder 18 til 85 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06084234Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
- Mass General Cancer Center, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06915753Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
- Massachusetts General Hospital, Boston
RekruttererFase 2
Alder 18 til 100 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07219459Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Mass General Brigham, Boston
RekruttererObservasjonsstudie
Alder 22 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06486454Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
RekruttererFase 1/2
12 Months – 30 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04851119FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT05919264Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
- Massachusetts General Hospital Cancer Center, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07166406First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
- Research Site, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06795022A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
RekruttererFase 1/2
Alder 1 til 21 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04634357Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 17. jun. 2026 · NCT05486572A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
RekruttererFase 1
Alder 16 og eldre · Alle kjønn · Oppdatert 2. jun. 2026 · NCT07197554Computer Guided Microwave Liver Ablation
- Massachusetts General Hospital, Boston
Rekrutterer
Alder 18 til 90 · Alle kjønn · Oppdatert 11. mai 2026 · NCT07226869Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
- Children's Hospital Boston, Boston
- Dana Farber Cancer Institute, Boston
RekruttererFase 2
Alder 0 til 30 · Alle kjønn · Oppdatert 24. feb. 2026 · NCT04134559Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Massachussets General Hospital, Boston
RekruttererFase 4
Alder 18 til 64 · Alle kjønn · Oppdatert 22. jan. 2026 · NCT04373564SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Worcester
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
RekruttererObservasjonsstudie
Alder 18 til 99 · Alle kjønn · Oppdatert 26. sep. 2025 · NCT06265272Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
- Massachusetts General Hospital, Boston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 29. aug. 2025 · NCT06541990Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.